It was previously reported that bvPLA2 had anti-inflammatory and analgesic effects in rodent models of Parkinson’s disease, asthma, neuropathic pain, and drug-induced liver and kidney injuries via modulation of Foxp3+ regulatory T cells12–16. Here, FOXP3 is linked to Parkinson disease.